{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:36:03Z","timestamp":1792791363238,"version":"4.5.0"},"reference-count":33,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T00:00:00Z","timestamp":1641168000000},"content-version":"unspecified","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>This study aims to identify levels of adherence to antiretroviral therapy (ART) drugs and factors associated with them in Northwest Ethiopia. We hypothesise that in the era of COVID-19, there would be suboptimal adherence to ART drugs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>An observational cross-sectional study was conducted. Factors associated with the level of adherence were selected for multiple logistic regressions at a p value of less than 0.2 in the analysis. Statistically significant associated factors were identified at a p value less than 0.05 and adjusted OR with a 95% CI.<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting<\/jats:title><jats:p>The study was conducted in one specialised hospital and three district hospitals found in the South Gondar zone, Northwest Ethiopia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Participants<\/jats:title><jats:p>About 432 people living with HIV\/AIDS receiving highly active ART in South Gondar zone public hospitals and who have been on treatment for more than a 3-month period participated in the study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Primary and secondary outcome measures<\/jats:title><jats:p>Levels of adherence to ART drugs and their associated factors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among 432 study participants, 81.5% (95% CI: 78% to 85.2%) of participants were optimally adherent to ART drugs. Determinants of a low level of adherence: stigma or discrimination (OR=0.4, p=0.016), missed scheduled clinical visit (OR=0.45, p=0.034), being on tuberculosis treatment (OR=0.45, p=0.01), recent CD4 cell count less than 500 cells\/mm<jats:sup>3<\/jats:sup> (OR=0.3, p=0.023) and patients who had been on WHO clinical stage III at the time of ART initiation (OR=0.24, p=0.027) were factors significantly associated with adherence to ART drugs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Level of adherence was relatively low compared with some local studies. The intervention targeted to reduce discrimination, counselling before initiation of treatment and awareness regarding compliance is advised to improve adherence to antiretroviral regimens.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2021-056009","type":"journal-article","created":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T16:53:53Z","timestamp":1641228833000},"page":"e056009","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Magnitude of optimal adherence and predictors for a low level of adherence among HIV\/AIDS-infected adults in South Gondar zone, Northwest Ethiopia: a multifacility cross-sectional study"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3507-9612","authenticated-orcid":false,"given":"Shimeles Biru","family":"Zewude","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tewodros Magegnet","family":"Ajebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,1,3]]},"reference":[{"key":"2022010308153314000_12.1.e056009.1","unstructured":"UNAIDS . Global HIV\/AIDS statistics-fact sheet, 2020."},{"key":"2022010308153314000_12.1.e056009.2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1089\/apc.2010.0378","article-title":"Aids in Brazilian children: history, surveillance, antiretroviral therapy, and epidemiologic transition, 1984-2008","volume":"25","author":"Ramos","year":"2011","journal-title":"AIDS Patient Care STDS"},{"key":"2022010308153314000_12.1.e056009.3","doi-asserted-by":"crossref","unstructured":"Wubshet M , Berhane Y , Worku A , et al . High loss to follow-up and early mortality create a substantial reduction in patient retention in antiretroviral treatment programs in Northwest Ethiopia. Isrn AIDS 2012.","DOI":"10.5402\/2012\/721720"},{"key":"2022010308153314000_12.1.e056009.4","unstructured":"UNAIDS and World Health Organization . Global HIV\/AIDS response: epidemic update and health sector progress towards universal access: progress report 2011. Global HIV\/AIDS response: epidemic update and health sector progress towards universal access: progress report 2011."},{"key":"2022010308153314000_12.1.e056009.5","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-133-1-200007040-00004"},{"key":"2022010308153314000_12.1.e056009.6","unstructured":"Deleuze J , Sicard D , Coste J . Enqu\u00eate SUR l'observance des traitements antir\u00e9troviraux comportant un inhibiteur de prot\u00e9ase CheZ les patients infect\u00e9s par le VIH. Annales de m\u00e9decine interne 2000."},{"key":"2022010308153314000_12.1.e056009.7","unstructured":"HIV\/AIDS Prevention and Control Office . Guidelines for pediatric HIV\/AIDS care and treatment in Ethiopia. Addis Ababa: HIV\/AIDS Prevention and Control Office, 2008."},{"key":"2022010308153314000_12.1.e056009.8","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-007-0028-8"},{"key":"2022010308153314000_12.1.e056009.9","first-page":"34","article-title":"[Influence of antiretroviral therapy characteristics on pediatric patient adherence]","volume":"28","author":"Esteban G\u00f3mez","year":"2004","journal-title":"Farm Hosp"},{"key":"2022010308153314000_12.1.e056009.10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1089\/apc.2010.0181","article-title":"Medication adherence in children and adolescents with HIV infection: associations with behavioral impairment","volume":"25","author":"Malee","year":"2011","journal-title":"AIDS Patient Care STDS"},{"key":"2022010308153314000_12.1.e056009.11","unstructured":"World Health Organization . The HIV drug resistance report. Geneva; Switzerland, 2012."},{"key":"2022010308153314000_12.1.e056009.12","doi-asserted-by":"publisher","DOI":"10.1080\/09540120050042891"},{"key":"2022010308153314000_12.1.e056009.13","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-015-0753-y","article-title":"Determinants of antiretroviral adherence among HIV positive children and teenagers in rural Tanzania: a mixed methods study","volume":"15","author":"Nyogea","year":"2015","journal-title":"BMC Infect Dis"},{"key":"2022010308153314000_12.1.e056009.14","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2004.20.1053"},{"key":"2022010308153314000_12.1.e056009.15","first-page":"355","article-title":"Adherence to antiretroviral therapy and its associated factors among people living with HIV\/AIDS in Addis Ababa, Ethiopia","volume":"50","author":"Mengistu","year":"2012","journal-title":"Ethiop Med J"},{"key":"2022010308153314000_12.1.e056009.16","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0b013e32835b8123"},{"key":"2022010308153314000_12.1.e056009.17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.6.679"},{"key":"2022010308153314000_12.1.e056009.18","unstructured":"UNAIDS . 90\u201390\u201390 - An ambitious treatment target to help end the AIDS epidemic 2017."},{"key":"2022010308153314000_12.1.e056009.19","doi-asserted-by":"publisher","DOI":"10.1086\/339074"},{"key":"2022010308153314000_12.1.e056009.20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12914-015-0071-x","article-title":"Factors associated with adherence to antiretroviral therapy (art) among adult people living with HIV and attending their clinical care, eastern Ethiopia","volume":"15","author":"Letta","year":"2015","journal-title":"BMC Int Health Hum Rights"},{"key":"2022010308153314000_12.1.e056009.21","first-page":"2","article-title":"Adherence to antiretroviral treatment and associated factors among people living with HIV\/AIDS in Northwest Ethiopia","volume":"2","author":"Tadesse","year":"2014","journal-title":"J Trop Dis"},{"key":"2022010308153314000_12.1.e056009.22","doi-asserted-by":"publisher","DOI":"10.1186\/1742-6405-7-1"},{"key":"2022010308153314000_12.1.e056009.23","first-page":"75","article-title":"Assessment of adherence to highly active antiretroviral therapy and associated factors among people living with HIV at Debre Berhan referral hospital and health center, northeast Ethiopia: a cross-sectional study","volume":"7","author":"Ketema","year":"2015","journal-title":"HIV\/AIDS"},{"key":"2022010308153314000_12.1.e056009.24","article-title":"Adherence to antiretroviral therapy and associated factors among people living with HIV\/AIDS in Hara town and its surroundings, north-eastern Ethiopia: a cross-sectional study","volume":"29","author":"Legesse","year":"2019","journal-title":"Ethiop J Health Sci"},{"key":"2022010308153314000_12.1.e056009.25","unstructured":"Awel M . Antiretroviral adherence, and its detriments among people living with HIV\/AIDS on highly active antiretroviral therapy in two hospitals of Oromiya regional state. Ethiopia. Ethiopian public health association (EPHA) extract from EPHA\u2014sponsored master thesis on HIV\/AIDS 2008;4: :9\u201319."},{"key":"2022010308153314000_12.1.e056009.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2009.04.002"},{"key":"2022010308153314000_12.1.e056009.27","doi-asserted-by":"crossref","DOI":"10.7448\/IAS.16.3.18640","article-title":"Impact of HIV-related stigma on treatment adherence: systematic review and meta-synthesis","volume":"16","author":"Katz","year":"2013","journal-title":"J Int AIDS Soc"},{"key":"2022010308153314000_12.1.e056009.28","article-title":"Adherence to antiretroviral therapy in Nigeria: an overview of research studies and implications for policy and practice","volume":"2","author":"Monjok","year":"2010","journal-title":"Hiv Aids"},{"key":"2022010308153314000_12.1.e056009.29","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2015.302695"},{"key":"2022010308153314000_12.1.e056009.30","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200205030-00012"},{"key":"2022010308153314000_12.1.e056009.31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13643-020-01524-1","article-title":"Factors associated with antiretroviral treatment failure among people living with HIV on antiretroviral therapy in resource-poor settings: a systematic review\u00a0and metaanalysis","volume":"9","author":"Lailulo","year":"2020","journal-title":"Syst Rev"},{"key":"2022010308153314000_12.1.e056009.32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030438"},{"key":"2022010308153314000_12.1.e056009.33","unstructured":"UNAIDS . AIDS by the numbers 2015. Geneva Switzerland: UNAIDS, 2015."}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-056009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T16:54:17Z","timestamp":1641228857000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-056009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1,3]]},"published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.1136\/bmjopen-2021-056009"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-056009","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}